RTW Investments’s Bristol-Myers Squibb BMY Stock Holding History

RTW Investments’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-7,500	Closed	-$2.59M	–	41
2015 Q3	$2.59M	Buy	+7,500	New	+$476K	0.8%	21
2015 Q2	–	Hold	0	–	–	–	17

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

RTW Investments's BMY Position: Q2 2020 in Review

RTW Investments sold out of Bristol-Myers Squibb (BMY) in Q2 2020, closing a stake of 1,685,934 shares — an estimated $94M sold.

RTW Investments first reported a position in BMY in Q2 2015 and held it in 20 quarters. The position peaked at $105M in Q4 2019. 2,190 funds tracked by Wall St. Rank hold BMY as of Q2 2020.

RTW Investments reported no remaining Bristol-Myers Squibb position as of Q2 2020 after selling out during the quarter.
RTW Investments sold 1,685,934 Bristol-Myers Squibb shares in Q2 2020, an estimated $94M.
RTW Investments first reported a position in Bristol-Myers Squibb in Q2 2015 and held it in 20 quarters.
RTW Investments's Bristol-Myers Squibb position peaked at $105M in Q4 2019.
2,190 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2020.

Based on RTW Investments's 13F filing for Q2 2020, filed 14 Aug 2020.